Business Description
Aelis Farma SA is a French drug development company founded in 2013 and based in Bordeaux, focused on treating brain and nervous system conditions. Its two main drug candidates work by targeting a specific receptor in the brain called CB1, and both are currently in Phase 2 clinical trials. The first, AEF0117, aims to reduce the harmful effects of heavy cannabis use, while the second, AEF0217, is being tested as a treatment for memory and thinking problems associated with Down syndrome and similar conditions.
